Abivax S.A. (0RA9.L) LSE

74.30

+3.4(+4.80%)

Updated at September 08 02:46PM

Currency In EUR

Valuation

Market Cap426.19M
Enterprise Value379.33M
P/E Ratio-27.56
PEG Ratio-2.16
Price/Sales Ratio538.51
Price/Book Ratio119.67
Enterprise/Revenue534.17
Enterprise/EBITDA-33.58

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-16.33
Operating Margin-17.18

Management Effectiveness

Return On Assets-0.86
Return On Equity-2.11

Income Statement

Revenue10.79M
Revenue/Share0.17
Gross Profit10.79M
EBITDA-167.68M
Net Income-176.24M
Diluted EPS-2.8

Balance Sheet

Total Cash144.22M
Total Cash/Share2.28
Total Debt97.36M
Total Debt/Equity2.4
Current Ratio1.82
Book Value Per Share0.64

Price History

52-Week Change582.62
52-Week High77.2
52-Week Low5.68
Moving Average 50 Days11.44
Moving Average 200 Days13.25

Statistics

Average Volume5,413
Shares Outstanding75.57M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A